NCT06203977View on ClinicalTrials.gov

Inflammation REduction to Prevent cArdiovascular Injury in Renal Disease (REPAIR)

PHASE1RecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

November 15, 2024

Primary Completion Date

May 31, 2026

Study Completion Date

May 31, 2026

Conditions
Chronic Kidney DiseasesRenal Failure
Interventions
DRUG

Colchicine

0.3mg and 0.6mg tablets

Trial Locations (3)

T6G 2B7

NOT_YET_RECRUITING

University of Alberta Hospital, Edmonton

L8N 4A6

RECRUITING

St. Joseph's Healthcare Hamilton, Hamilton

N6A 5A5

NOT_YET_RECRUITING

London Health Sciences Centre, London

All Listed Sponsors
collaborator

Hamilton Academic Health Sciences Organization

OTHER

collaborator

St. Joseph's Health Care London

OTHER

lead

Hamilton Health Sciences Corporation

OTHER